Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Buruli Ulcer Diagnosed by Fluorescent Thin Layer Chromatography

By LabMedica International staff writers
Posted on 29 Nov 2015
Mycobacterium ulcerans infection, known as Buruli ulcer, is a disease of the skin and subcutaneous tissues which is an important but neglected tropical disease with its major impact in rural parts of West and Central Africa where facilities for diagnosis and management are poorly developed. More...


Since prevention is not possible in the absence of either an effective vaccine or a clear understanding of the mode of transmission, a major control strategy for Buruli ulcer is early detection and treatment, hinging on effective laboratory confirmation of suspected cases. Standard routine laboratory techniques for the confirmation of Buruli ulcer disease are M. ulcerans isolation by culture, histopathology, smear microscopy for acid-fast bacilli (AFB) and polymerase chain reaction (PCR).

A team of international scientists led by those at Kwame Nkrumah University of Science and Technology (KNUST) (Kumasi, Ghana) recruited patients from Buruli ulcer treatment centers from January 2014 to June 2014 in Benin, DR Congo, Ghana and Côte d’Ivoire if they had a skin lesion suspected to be caused by M. ulcerans infection. Samples were collected by fine needle aspiration (FNA) or swab according to whether the lesion was non-ulcerated or ulcerated respectively and by biopsy if obtained at surgery. If PCR for the M. ulcerans repeat sequence IS2404 was positive they were included as Buruli ulcer disease patients and if the PCR was negative they were included in the control group.

The team evaluated fluorescent thin layer chromatography (f-TLC) for detection of mycolactone in the laboratory using samples from patients with Buruli ulcer and patients with similar lesions that gave a negative result on PCR. The f-TLC used was a modification of an existing methodology. The TLC plates were placed on an ultra violet lamp with a 365 nm filter. The fluorescent band at retention factor 0.23 from the patient sample was compared to that of the standards to confirm the presence of mycolactone. Two readers were made to confirm the mycolactone test result before test result reporting and were blinded to the PCR test result.

There were 71 IS2404 PCR positive samples and 28 PCR negative samples which were used as controls. The scientists found that mycolactone can be detected in 73% of M. ulcerans infected samples by fluorescent thin layer chromatography. The technique was easy to perform and the result could be read within one hour. The sensitivity was higher than that of microscopy (30–60%) or culture (35%–60%) and compared favorably with that of histology (82%). There was no difference in sensitivity when FNA and swabs were compared although the number of FNA samples was small.

The authors concluded that that mycolactone can be detected from M. ulcerans infected skin tissue by f-TLC technique. The technique is simple, easy to perform and read with minimal costs. In this study it was undertaken by a member of the group from each endemic country. It is a potentially implementable tool at the district level after evaluation in larger field studies. The study was published on November 19, 2015, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Kwame Nkrumah University of Science and Technology 



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.